Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
US FDA accepts Boehringer Ingelheims supplemental new drug application
To be used for use of dabigatran etexilate mesylate in deep vein thrombosis and pulmonary embolism
Bilcare starts field validation studies of its nonClonableID technology
Developed in collaboration with CSIR, the system aims to secure the pharma supply chain as well as improve patient compliance
Zandu Ayurveda launches its first clinic at Nature Cure & Yoga Centre in Kolkata
Plans to launch more clinics in other select cities
Lupin receives US FDA approval for generic rifadin capsules
Is indicated for the treatment of all forms of tuberculosis
Expansion of product offerings with focus on cancer therapeutics drives M&A activity
India market sees no deals in August ‘13
Piramal Healthcare to invest $11 million at its UK facility
Work on the new suite, which will house formulation, packaging coating and tableting equipment, will commence at the end of 2013
PSM India organises workshops on pharmacovigilance
Stakeholders across the spectrum deliberated on the current state of pharmacovigilance and ways to make the system stronger.…
National Forum on Tuberculosis holds first meeting in New Delhi
Discusses the rise and challenges of drug-resistant TB in India
OPPI seminar debates healthcare access in India
The event saw the presence of distinguished professionals, acclaimed experts and scientists from the Indian healthcare industry…